Literature DB >> 1653671

Angiotensin II augments sympathetically mediated arteriolar constriction in man.

P H Seidelin1, J G Collier, A D Struthers, D J Webb.   

Abstract

1. In animal studies, angiotensin II facilitates adrenergic neurotransmission by both pre- and post-synaptic mechanisms. We have investigated whether this interaction occurs in forearm resistance vessels in man. 2. The effect of arterial infusion of angiotensin II (320 fmol/min) on sympathetic vasoconstriction produced by lower-body negative pressure (15 mmHg) was studied in six subjects, and that on the response to exogenous noradrenaline (37.5-150 pmol/min) was studied in a further eight subjects. Forearm blood flow was measured by strain-gauge plethysmography. 3. The dose of angiotensin II was chosen to produce no alteration in resting blood flow, and those of noradrenaline were selected to provide a reduction in blood flow equivalent to that produced by lower-body negative pressure. 4. Lower-body negative pressure produced no change in heart rate or diastolic blood pressure, but caused an initial 5 mmHg fall in systolic blood pressure (P less than 0.01). Blood flow was reduced by 21 +/- 6% in both forearms by lower-body negative pressure during saline infusion. During angiotensin II infusion, there was a marked difference in the response to lower-body negative pressure, with blood flow being reduced by 40 +/- 7% in the infused arm, but only by 21 +/- 4% in the control arm (P less than 0.05). Angiotensin II infusion had no effect on resting blood flow or the responses to noradrenaline. 5. We conclude that angiotensin II augments sympathetic vasoconstriction in forearm resistance vessels in man at a concentration that has no direct effect on blood flow.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1653671     DOI: 10.1042/cs0810261

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  5 in total

Review 1.  Genetic determinants of vascular reactivity.

Authors:  Daniel Henrion; Joelle Benessiano; Marc Iglarz; Ivan Philip; Bernard I Levy
Journal:  Curr Hypertens Rep       Date:  2002-02       Impact factor: 5.369

Review 2.  Venous occlusion plethysmography in cardiovascular research: methodology and clinical applications.

Authors:  I B Wilkinson; D J Webb
Journal:  Br J Clin Pharmacol       Date:  2001-12       Impact factor: 4.335

3.  Sympathetic nerve damage as a potential cause of lymphoedema after axillary dissection for breast cancer.

Authors:  T M Bennett Britton; S M L Wallace; I B Wilkinson; P S Mortimer; A M Peters; A D Purushotham
Journal:  Br J Surg       Date:  2009-08       Impact factor: 6.939

4.  An investigation into the direct and indirect venoconstrictor effects of endothelin-1 and big endothelin-1 in man.

Authors:  W G Haynes; S Moffat; D J Webb
Journal:  Br J Clin Pharmacol       Date:  1995-10       Impact factor: 4.335

5.  Regulation of peripheral vascular tone in patients with heart failure: contribution of angiotensin II.

Authors:  D E Newby; N E Goodfield; A D Flapan; N A Boon; K A Fox; D J Webb
Journal:  Heart       Date:  1998-08       Impact factor: 5.994

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.